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Eukaryotic-Type Ser/Thr Protein
Kinase Mediated Phosphorylation of
Mycobacterial Phosphodiesterase
Affects its Localization to the Cell
Wall
Neha Malhotra and Pradip K. Chakraborti *
CSIR-Institute of Microbial Technology, Chandigarh, India
Phosphodiesterase enzymes, involved in cAMP hydrolysis reaction, are present
throughout phylogeny and their phosphorylation mediated regulation remains elusive
in prokaryotes. In this context, we focused on this enzyme from Mycobacterium
tuberculosis. The gene encoded by Rv0805 was PCR amplified and expressed
as a histidine-tagged protein (mPDE) utilizing Escherichia coli based expression
system. In kinase assays, upon incubation with mycobacterial Clade I eukaryotic-type
Ser/Thr kinases (PknA, PknB, and PknL), Ni-NTA purified mPDE protein exhibited
transphosphorylation ability albeit with varying degree. When mPDE was co-expressed
one at a time with these kinases in E. coli, it was also recognized by an
anti-phosphothreonine antibody, which further indicates its phosphorylating ability. Mass
spectrometric analysis identified Thr-309 of mPDE as a phosphosite. In concordancewith
this observation, anti-phosphothreonine antibody marginally recognized mPDE-T309A
mutant protein; however, such alteration did not affect the enzymatic activity. Interestingly,
mPDE expressed in Mycobacterium smegmatis yielded a phosphorylated protein that
preferentially localized to cell wall. In contrast, mPDE-T309A, the phosphoablative variant
of mPDE, did not show such behavior. On the other hand, phosphomimics of mPDE
(T309D or T309E), exhibited similar cell wall anchorage as was observed with the
wild-type. Thus, our results provide credence to the fact that eukaryotic-type Ser/Thr
kinase mediated phosphorylation of mPDE renders negative charge to the protein,
promoting its localization on cell wall. Furthermore, multiple sequence alignment revealed
that Thr-309 is conserved among mPDE orthologs of M. tuberculosis complex, which
presumably emphasizes evolutionary significance of phosphorylation at this residue.
Keywords: signal transduction, cAMP, eukaryotic-type serine/threonine kinase, enzyme activity, mutagenesis,
intracellular trafficking, phosphodiesterase
Abbreviations: cAMP, 3′, 5′- cyclic adenosine monophosphate; mPDE, M. tuberculosis phosphodiesterase; MBP, Maltose
Binding Protein; His6, 6X Histidine tag; OADC, Oleic acid albumin dextrose catalase growth enrichment; LC-MS/MS, Liquid
chromatography coupled tandem mass spectrometry;Msm,M. smegmatis.
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INTRODUCTION
Cells respond to various environmental changes by an orchestra
of events and transfer information through the process of
signal transduction (McDonough and Rodriguez, 2012). The
cascade of events involve identification as well as amplification
of signals resulting in gene(s) expression that regulates cellular
physiology of an organism and ultimately helps to better
acclimatize in the adverse environs for its survival. In this
direction, we concentrated on bacterial signaling, especially
focussing on pathogens like Mycobacterium tuberculosis, the
causative agent of the disease tuberculosis (Chevalier et al., 2014).
In fact, M. tuberculosis is considered to be one of the most
successful pathogen as it is capable of withstanding host defense
mechanism(s) for its survival (Chevalier et al., 2014; Dey and
Bishai, 2014; Orme, 2014). Such compliance might be attributed
to its ability to camouflage within the micro-environment of
the host and exhibit atypical or unique signal transduction
mechanisms. In this context, signaling involving small molecules
such as 3′, 5′-cyclic AMP, cyclic di-AMP, cyclic di-GMP etc.,
are less explored (Hong et al., 2013; Zaveri and Visweswariah,
2013; Manikandan et al., 2014). These cyclic nucleotide levels are
controlled by different phosphodiesterases by promoting their
hydrolytic degradation and thus, play a crucial role in the process
(Shenoy et al., 2005; Hong et al., 2013; Yang et al., 2014).
Analysis of M. tuberculosis genome sequence revealed the
presence of an exceptionally high 3′, 5′- cAMP synthesizing
machinery in the form of adenylate cyclases compared to other
micro-organisms. While 16 such genes have been identified in
M. tuberculosis genome (Shenoy and Visweswariah, 2006; Zaveri
and Visweswariah, 2013), there is only one phosphodiesterase
(mPDE) enzyme that antagonizes cAMP action through its
degradation into 5′AMP (Shenoy et al., 2005; Chakraborti et al.,
2011). Apart from cAMP hydrolysis, mPDE is also involved
in altering cell wall permeability (Podobnik et al., 2009). The
mPDE has already been characterized and its structure was
determined using X-ray crystallographic studies (Shenoy et al.,
2007). While its N-terminal catalytic domain is responsible
for the enzyme activity, the C-terminal region mediates its
localization (Podobnik et al., 2009; Matange et al., 2014).
The presence of ortholog of mPDE in the minimal genome
of Mycobacterium leprae further signifies its importance in
mycobacterial signal transduction (Shenoy et al., 2005). PDEs
in humans are regulated by phosphorylation through Ser/Thr
kinases like cAMP- dependent protein kinase A (PKA) or
protein kinase B (PKB), thus influencing their catalytic ability
(Macphee et al., 1988; Kitamura et al., 1999; Lindh et al.,
2007; Bessay et al., 2008). To our surprise, till date there have
been no reports of phosphorylation mediated regulation of any
bacterial PDE, including that from M. tuberculosis. Although
M. tuberculosis possesses highly complex as well as dynamic
phosphorylation/dephosphorylationmachinery comprising of 11
eukaryotic-type Ser/Thr kinases and the cognate phosphatase
(Cole et al., 1998; Chakraborti et al., 2011), their involvement
in this process is yet unknown. Recent studies indicated that
these kinases have several cellular targets and they regulate
a plethora of metabolic events in prokaryotes (Pereira et al.,
2011). Bioinformatic analysis of these 11 mycobacterial kinases
categorized them in five groups, Clades I-V (Narayan et al.,
2007). Among these kinases, we concentrated on PknA from
M. tuberculosis belonging to Clade I. Like other eukaryotic-type
Ser/Thr kinases, PknA has a characteristic domain structure and
it is predominantly phosphorylated at threonine residues (Chaba
et al., 2002; Thakur et al., 2008; Ravala et al., 2015). Available
literature also established the role of PknA in morphological
changes associated with bacterial cell division (Chaba et al.,
2002; Kang et al., 2005) by interacting with FtsZ and MurD.
Notably, the FtsZ protein andMurD enzyme play a crucial role in
bacterial cytokinesis and peptidoglycan respectively (Thakur and
Chakraborti, 2006, 2008).
In this study, we provide evidence that mPDE is
transphosphorylated by PknA. Among other mycobacterial
Clade I kinases, we noticed PknB and PknL were also able to
phosphorylate mPDE albeit with varying magnitude. Utilizing
PknA as a representative of mycobacterial eukaryotic-type
Ser/Thr kinases, its co-expression with mPDE in Escherichia
coli yielded a phosphorylated His-tagged protein. LC-MS/MS
identified Thr-309 as the phosphorylable residue in this
protein, which is located within a short but de-structured
C-terminal domain of mPDE (Podobnik et al., 2009; Matange
et al., 2014). The mPDE upon expression in Mycobacterium
smegmatis was recognized by anti-phosphothreonine antibody.
Further, our analysis on phosphoablative and phosphomimetic
substitutions of the phospho-threonine residue indicated the
role of eukaryotic-type Ser/Thr kinase mediated phosphorylation
of mPDE for its cell wall association. Interestingly, Thr-309 is
conserved amongst mPDE orthologs of M. tuberculosis complex
portraying its probable evolutionary significance.
MATERIALS AND METHODS
Materials
Restriction enzymes were procured from New England
Biolabs (USA). Other fine biochemicals like ATP, Tris, NaCl,
maltose, MnCl2, MgCl2, trypsin and dephosphorylated α-
casein were procured from Sigma (USA). Antibodies like
anti-phosphothreonine (Cell Signalling Technology, USA)
and anti-His (GE Healthcare, USA) were commercially
available. Phosphodiesterase assay kit was the product of
Enzo R©Lifesciences (USA). [γ-32P] ATP was obtained from
Board of Radiation and Isotope Technology (BRIT, India).
Desalted oligonucleotides were custom synthesized from Sigma.
Cloning, Expression, and Site Directed
Mutagenesis
Different genes were isolated through PCR amplification
using genomic DNA from M. tuberculosis strain H37Ra as
the template. In fact, sequences of mPDE (Rv0805), pknB
(Rv0014c), and pknL (Rv2176) were identical at nucleotide level
between pathogenic (H37Rv) and non-pathogenic (H37Ra)
strains of M. tuberculosis. For amplification of mPDE gene, PCR
(denaturation: 5min at 95◦C; reaction: 1min at 95◦C, 0.5min
at 58◦C, 0.5min at 72◦C for 29 cycles; final extension: 10min
Frontiers in Microbiology | www.frontiersin.org 2 February 2016 | Volume 7 | Article 123
Malhotra and Chakraborti Phosphorylation of Mycobacterial Phosphodiesterase
at 72◦C) was carried out using Herculase DNA polymerase
enzyme, primers incorporating restriction sites (CN15: 5′- ACG
TACGAATTCCATATGCATAGACTTAGGG-3′ and CN16:
5′- CTAGACAAGCTTTCAGTCGACGGGACTTC-3′) and
template DNA. Amplified DNA fragments were cloned either in
pET-28c/pVV2 (at NdeI/HindIII sites for mPDE) or in pMAL-
c2X (BamHI/HindIII for PknB or PknL) and maintained as pET-
mPDE/pVV2-mPDE/pMAL-PknB/pMAL-PknL in E. coli strain
DH5α. PknB (PCR amplified using 5′- AATTAGGATCCCAT
ATGACCACCCCTCCC-3′ and 5′- ACTGCAAGCTTCTA
CTGGCCGAACCT-3′ primers) and PknL (PCR amplified using
5′- AACTTGGATCCCATATGGTCGAAGCTGGCACG-3′ and
5′- GGAATTAAGCTTTTACAGCAGGCCGCTCAGGTTG-3′
primers) constructs were available in the lab. The pET-mPDE
construct was transformed in E. coli strain BL21(DE3) for protein
expression and purification. Besides these, pMAL-PknA/-PknA-
core/-PknA-K42N, p19kpro-PknA/-PknA-K42N (Rv0015c or
its variant containing amino terminal 338 residues or its PknA-
K42N mutant either in pMAL or p19kpro) and pMAL-PPP
(Rv0018c in pMAL) used in this study were described earlier
(Chaba et al., 2002; Thakur and Chakraborti, 2006, 2008; Thakur
et al., 2008; Ravala et al., 2015).
mPDE-T309A, mPDE-T309D and mPDE-T309E mutants
were generated by employing overlap extension PCR method
(Ho et al., 1989) using pET-mPDE DNA as the template.
Primary PCR was performed using two sets of primers for
each mutant (set 1: terminal forward, CN15 and internal
reverse, CN54: 5′-TGCCGAGGACGCCAGCACCAT-3′;
set 2: internal forward, CN53: 5′-ATGGTGCTGGCGTCC
TCGGCA-3′ and terminal reverse, CN16 for mPDE-T309A;
set1: CN15, and CN57: 5′- ATGGTGCTGGACTCCTCGGCA-
3′; set2: CN58: 5′- TGCCGAGGAGTCCAGCACCAT-3′
and CN16 for mPDE-T309D; set 1: CN15 and CN59:
5′- ATGGTGCTGGAATCCTCGGCA-3′; set 2: CN60: 5′-
TGCCGAGGATTCCAGCACCAT-3′ and CN16 for mPDE-
T309E). For secondary PCR, two independent fragments
generated in this way were mixed at equi-molar concentrations
(1:1), amplified using primers (CN15 and CN16) and cloned in
pET-28c or pVV2 vectors.
Recombinant proteins expressed in E. coli were purified
following protocol described earlier with slight modifications
(Chaba et al., 2002). Briefly, fresh culture (1% inoculum from
overnight cultures) using LB broth with appropriate antibiotics
was grown till OD600 of 0.6–0.8, induced with 0.4mM IPTG and
further incubated at 37◦C for 3 h. This was followed by harvesting
and resupension of cell pellet in lysis buffer (50mM Tris-HCl,
pH 7.5 and 150mM NaCl) along with protease inhibitors (1mM
phenylmethylsulfonylfluoride, 1µg/ml pepstatin and 1µg/ml
leupeptin). Cells were lysed by sonication (over ice; 10 s “on”
and 10 s “off” cycles for 10min; 20% amplitude) and centrifuged
at 18,000 × g at 4◦C for 60min. The supernatant fraction was
loaded onto Ni-NTA affinity column equilibrated with 10mM
imidazole in lysis buffer. Column was washed with 20mM
imidazole in lysis buffer and protein was eluted using 50–200mM
imidazole in lysis buffer.
ThemPDE ormPDE-T309A/D/E variants were also expressed
in M. smegmatis strain mc2155 following its cloning in pVV2
vector (Dhiman et al., 2004; Thakur and Chakraborti, 2008) at
NdeI/HindIII sites (pVV2-mPDE or pVV2-mPDE-T309A/D/E).
These constructs were transformed by electroporation in
M. smegmatis strain mc2155 following standard procedure
(Thakur and Chakraborti, 2008). Cells harboring wild-type
or mutants in pVV2 vector constructs were inoculated in
Middlebrook 7H9 media enriched with OADC (10%) and
Tween-80 in presence of kanamycin (25µg/ml) and grown at
37◦C at 200 rpm for 24 h (OD600 of ∼0.8). Following their
inoculation (1% inoculum) in LB media supplemented with
kanamycin (25µg/ml) at 37◦C till OD600 of 0.6-0.8, cells
were induced with H2O2 (0.002%) and grown further in same
conditions for 6 h. For purification of recombinant proteins, cells
were then processed as mentioned above for E. coli expression
system except for slightly altered procedure for sonication (20 s
“on,” 40 s “off” 40% amplitude for 60min over ice). Finally,
protein was eluted with 250mM imidazole (in lysis buffer),
aliquoted in small fractions and stored at −80◦C till further
use. For preparation of sub-cellular fractions, cellular lysis was
accomplished by 2-3 passages through French Press at 1500 psi
FIGURE 1 | Mycobacterial PDEs are phylogenetically distinct. PDE
sequences from organisms of different taxa were used to obtain phylogenetic
relationship of mPDE. PDE sequences from few mycobacterial species, Gram
positive and negative bacteria and eukaryotes were used to obtain
phylogenetic tree of radiation type by neighbor joining method using Mega 6.0
software. Numerical values on the nodes represent the bootstrap confidence
and scale denotes evolutionary distance.
Frontiers in Microbiology | www.frontiersin.org 3 February 2016 | Volume 7 | Article 123
Malhotra and Chakraborti Phosphorylation of Mycobacterial Phosphodiesterase
followed by sonication (all parameters same as mentioned above
except time for 30min). The lysate was then centrifuged at 8000
× g at 4◦C for 5min for removal of unbroken cells/cellular
debris. Centrifugation was repeated at 18,000 × g at 4◦C for
1 h to separate pellet from supernatant. The obtained pellet
after suspending in lysis buffer was further extracted with 2%
SDS (65◦C for 2 h) and the supernatant fraction obtained after
centrifugation (18,000 × g at 25◦C for 45min) was used as the
cell wall fraction (Wang et al., 2000; Dave et al., 2002; Gibbons
et al., 2007). On the other hand, supernatant obtained after cell
lysis was ultracentrifuged at 110,000 x g at 4◦C for 2 h. Orange-
brown pellet obtained was used as the membrane fraction after
resuspending in lysis buffer (400µl), while the supernatant was
the cytosolic part.
Kinase Assay
Transphosphorylation of His6-mPDE by PknA (full length
construct containing 431 amino acids or N-terminal 338 amino
FIGURE 2 | Phosphorylation of mPDE by PknA. (A) In vitro phosphorylation of mPDE. MBP (0.89µM)/MBP-PknA Core (0.5µM)/MBP-PknA-K42N (0.44µM) were
briefly incubated with Ni-NTA purified 1 (1.32µM) or 10µg (13.2µM) mPDE. Samples were processed as described under “Materials and Methods.” Coomassie
stained radioactive gel provided in lower panel was used as a loading control. (B) In vitro dephosphorylation of mPDE. Phosphorylated proteins were
dephosphorylated following incubation with PPP (10µg or 5µM) at 37◦C for 75min. Coomassie stained radioactive gel served as the loading control (lower panel).
(C) In vivo phosphorylation of mPDE. BL21(DE3) cell lysates expressing His6-mPDE along with either p19kpro-PknA or empty vector (p19kpro) or kinase dead mutant
(p19kpro-PknA-K42N) were probed with anti-PknA antibody (left upper panel) while ponceau-S stained blot (left lower panel) served as a loading control. Anti-PknA
antibody used in this study was generated in our laboratory (Thakur and Chakraborti, 2008). His6-tagged mPDE protein purified from these cells was immunoblotted
with anti-phosphothreonine (right upper panel) or anti-His (right lower panel) antibody. Notations used: LMW, low molecular weight marker; PPP, phospho
serine/threonine phosphatase.
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acid containing catalytic core; Thakur et al., 2008) or kinase dead
variant of PknA (PknA-K42N) or PKnB or PknL was assessed
utilizing an in vitro kinase assay reported earlier (Chaba et al.,
2002; Lakshminarayan et al., 2008). Briefly, PknA (0.28µM for
full length or 0.5µM for catalytic core) or PknB (0.23µM)
or PknL (0.57µM) or PknA-K42N (0.44µM) in 1X kinase
buffer (50mM Tris-Cl, pH 7.5 or 6.8 for PknL/50mM NaCl
containing MnCl2, 10mM for PknA/PknL/PknA-K42N or 3mM
for PknB, and 10mM MgCl2 only for PknL) and 2 µCi of
[γ-32P] ATP was incubated in the presence of mPDE (10µg
or 13.2µM/reaction) at 25◦C (30◦C for PKnL) for 30min
(total reaction volume = 20µl). To monitor PPP mediated
de-phosphorylation, it was added to the reaction mix (10µg
or 5µM/reaction) at this step and further incubated for
75min at 37◦C. The reaction was stopped by adding 5X SDS
buffer. Samples were resolved in 10% SDS-PAGE; gels were
stained with Coomassie Brilliant Blue. Gels were analyzed in
a phosphoimaging device (Fuji Film model FLA 9000) and/or
exposed to Kodak X-Omat/AR film for autoradiography.
Western Blotting
Purified proteins (usually 1µg) or whole cell lysates (usually
25µg) were resolved on 10% SDS-PAGE, transferred (120V) to
nitrocellulose membrane (0.45µ) usingmini-transblot apparatus
(Bio-Rad, USA), probed with either anti-His (1:3000) or anti-
RpoB (1:3000) or anti-phosphothreonine (1:1000) or anti-PknA
(1:1000) or anti-mPDE (1:1000) and anti-mouse (for anti-His
and anti-RpoB antibodies) or anti-rabbit IgG (1:5000) as primary
and secondary antibodies, respectively. For monitoring in vivo
phosphorylation, pET-mPDE or pET-mPDE-T309A was co-
transformed with pMAL-PknA or p19kpro-PknA or pMAL-
PknB or pMAL-PknL in E. coli BL21(DE3) cells and their
expression as a phosphorylated protein was detected employing
western blotting using an anti-phosphothreonine antibody as
described earlier (Thakur and Chakraborti, 2006). Proteins were
finally detected with luminata substrate (Millipore, USA) and
developed on X-ray films (Kodak, USA) followingmanufacturer’s
recommended protocol.
Phosphodiesterase Enzyme Activity
PDE assays were performed using an assay kit of
Enzo R©Lifesciences, which employs colorimetric detection
of hydrolysis of standard 3′, 5′- cAMP (substrate) by cyclic
nucleotide phosphodiesterase. Briefly, the catalytic activity of
mPDE (3µg or 3.96µM) mediated hydrolysis of 3′, 5′- cAMP
(0.05 – 0.8mM) into 5′AMP was monitored in presence of Mn2+
(200µM) at 30◦C in a coupled assay following its conversion
into adenosine and phosphate catalyzed by 5′ nucleotidase
enzyme (0.5 kU/µl). Phosphate such generated was detected by
BIOMOL GREEN™ dye at OD of 620 nm at room temperature.
Standard curve was prepared by using 5′AMP (0.25 to 3 nmol)
in PDE assay buffer that catalyzes its cleavage by 5′ nucleotidase
enzyme.
Mass Spectrometry
Samples for mass spectrometry were prepared following the
manufacturer’s recommended protocol using proteomics grade
dimethylated trypsin from porcine pancreas (Sigma, USA).
Briefly, Ni-NTA purified proteins in 100mM ammonium
bicarbonate buffer, pH 8.4 was digested in-solution with
trypsin at 37◦C for 16 h. For cell wall fractions, samples after
resolving in SDS-PAGE were eluted in 200mM ammonium
bicarbonate buffer, pH 8.4 containing 40% acetonitrile and
then trypsinized (37◦C for 16 h) in 40mM ammonium
bicarbonate buffer, pH 8.4 containing 9% acetonitrile. This
was followed by running samples on UHPLC system (1290
series, Agilent Technologies) with C8 column coupled to
6550 iFunnel QTOF LC/MS (Agilent Technologies, USA).
Electron spray ionization (ESI) was operated in positive
ion mode with an MS and MS/MS acquisitions rate of 2
and 4 spectra/second respectively. Peptide sequences were
identified utilizing ProteinPilot™ software (http://www.absciex.
com/products/software/proteinpilot-software) and Mascot
server (http://www.matrixscience.com) as well.
Sequence Analysis and Phylogeny
Reciprocal best blast hits were procured from MycoRRdb
database (Midha et al., 2012), multiple sequence alignment was
done byMuscle program (Edgar, 2004) and phylogenetic tree was
constructed by neighbor joining method (Bootstrap value of 500)
using Mega 6.0 software (Tamura et al., 2013).
FIGURE 3 | Phosphorylation of mPDE by mycobacterial endogenous
kinases. His6-mPDE cloned in pVV2 vector was expressed and purified from
M. smegmatis. Expression and phosphorylation status of mPDE in different
cellular fractions (P: pellet and S: supernatant) or Ni-NTA purified form (mPDE)
was determined by immunoblotting with anti-mPDE (middle panel) and
anti-phosphothreonine antibody (top panel). Whole cell lysate of M. smegmatis
was used a negative control for mPDE expression (lane 1). Polyclonal antibody
against mPDE was raised in rabbit following the method described elsewhere
(Sarin et al., 2001). Ponceau-S stained blot served as a loading control for the
same. Inset shows dose dependent increase in phospho-signal of mPDE
isolated from M. smegmatis (lanes 3, 4, and 5). Western blotting with anti-His
antibody unlike the other case (with anti-mPDE antibody) was done to prevent
saturation of blot at higher amounts of mPDE. Unphosphorylated and
phosphorylated mPDE protein purified from E. coli strain BL21(DE3) were used
as internal controls (inset, lanes 1 and 2). Notations used: WCL, whole cell
lysate; Msm, M. smegmatis.
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RESULTS
Phylogenic Placement of mPDE
We initiated our studies to have phylogenetic insights on
the placement of mPDE in relation to other bacteria as
well as eukaryotes. For this, the gene encoding mPDE
(Rv0805) was used as a query to search for the best
blast hits in different mycobacterial species. In order to
have a wider taxonomic distribution, we extended search in
NCBI and Pubmed databases to obtain sequences for few
phosphodiesterases present in eukaryotes, gram positive and
gram negative bacteria. Multiple sequence alignment using
Muscle algorithm followed by phylogenetic tree construction
using neighbor-joining method was performed for all the
sequences byMega 6.0 software. Radiation tree shows that mPDE
has a unique and distinct taxonomic distribution (Figure 1).
Interestingly, orthologs of mPDE are present only in members
of M. tuberculosis complex (viz. M. tuberculosis, Mycobacterium
africanum, Mycobacterium bovis, Mycobacterium canettii, M.
leprae, Mycobacterium ulcerans) along with other slow growing
bacilli (Mycobacterium marinum). It is pertinent to mention that
phosphodiesterases in Mycobacterium avium and M. smegmatis
(MSMEG_2647 and MSMEG_6343), are distantly placed from
M. tuberculosis (Figure 1).
Phosphorylation of mPDE by
Mycobacterial Eukaryotic-Type Ser/Thr
Kinases
A few of the eukaryotic phosphodiesterases (PDE3b, PDE4,
PDE5a, and PDE10A etc.) are functionally regulated by
PKA/PKB induced phosphorylation (Macphee et al., 1988;
Kitamura et al., 1999; Liu and Maurice, 1999; Kotera et al.,
2004; Lindh et al., 2007; Bessay et al., 2008; Charych et al.,
2010). However, no such phosphorylation mediated regulation
of PDE enzyme has ever been reported in any prokaryote.
To evaluate this aspect, mPDE protein was purified to
substantial homogeneity using Ni-NTA affinity based column
chromatography, which on resolving in 10% SDS-PAGE and
staining, yielded a major band with molecular mass of 38 ±
6 (Mean ± SD, n = 3) along with slight contamination as
discussed previously (Shenoy et al., 2005). We initiated our
studies using PknA as a representative of eukaryotic-type Ser/Thr
kinases in M. tuberculosis to study phosphorylation of mPDE.
Accordingly, in vitro kinase assay was performed wherein mPDE
was incubated in presence and absence of MBP-tagged PknA
core [amino terminal 338 residues containing catalytic and
juxtamembrane domains of the kinase that exhibited enzymatic
activity (Thakur et al., 2008)]. As shown in Figure 2A, PknA
core (0.5µM) was capable to trans-phosphorylate mPDE with
FIGURE 4 | mPDE is phosphorylated by Clade I mycobacterial Ser/Thr kinases. (A) In vitro phosphorylation of Ni-NTA purified mPDE with different
mycobacterial kinases belonging to Clade I. Kinase assay utilizing [γ- 32P] labeled ATP was performed by incubating MBP-tagged PknA (0.28µM) or PknB (0.23µM)
or PknL (0.57µM) with His-tagged mPDE purified from E. coli strain BL21(DE3) or α-casein (4µM, internal control) using protocol mentioned in the text. Reactions
were stopped by adding 5X SDS dye followed by heating at 90◦C for 5min. Samples were resolved in 10% SDS-PAGE gel and signals were visualized through a
phospho-imaging device. Coomassie stained gels were used as loading control. (B) In vivo phosphorylation of mPDE with clade I kinases. Recombinant His-tagged
mPDE protein was purified using Ni-NTA affinity chromatography of lysates from BL21(DE3) cells expressing either PknA or PknB or PknL in pMAL-c2 vector.
Phosphorylation status of the protein(s) was determined in western blot by probing with anti-phosphothreonine antibody (upper panel). Immunoblot (lower panel) using
anti-His antibody as the probe served as a loading control.
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an increase in phospho-signal between 1 (1.32µM) and 10µg
(13.2µM) of protein (lanes 5 and 6). However, phospho-
signal was lost significantly due to deficit kinase-substrate
interactions when an inactive mPDE (denatured by boiling at
95◦C for 5min) was used in the assay (lane 7). Similarly, no
signal was obtained when it was incubated with kinase dead
mutant MBP-PknA-K42N (lane 8). Furthermore, incubation of
phosphorylated protein (obtained after kinase assay) with only
Ser/Thr phosphatase PPP, at 37◦C for 75min led to loss of
phospho-signal of mPDE (Figure 2B; compare lanes 3 and 4).
Notably, Coomassie stained radioactive gels were used as loading
controls for the experiments (Figures 2A,B, lower panels).
To reveal the existence of phosphorylation of substrate protein
(mPDE) in vivo, mPDE was co-expressed with full length
PknA or kinase-dead variant PknA-K42N in E. coli BL21(DE3)
cells utilizing two incompatible vector systems (pET-28c and
constitutive expression vector p19kpro bearing same origin of
replication). Expression of PknA or PknA-K42N (along with
mPDE) was confirmed in E. coli cell lysates (5µg protein/lane) by
western blotting using anti-PknA antibody (observed molecular
mass = ∼45 kDa, lanes 2 and 4, Figure 2C upper left panel
and also see Figure S1). Ponceau-S staining of same blot served
as a loading control where mPDE bands in all lanes were
stained (Figure 2C, lower left panel and also see Figure S1).
Despite loading same amount of total protein in each lane (5µg),
variation in expression levels of mPDE was observed in Ponceau-
S stained blot, which was very likely the result of differential
selection pressure of two different antibiotics (kanamycin for
FIGURE 5 | Identification of Thr-309 as a phosphorylating residue. (A) Identification of phosphorylated residue by LC-MS/MS. Phosphorylated His6-mPDE
(obtained when co-expressed with pMAL-PknA in BL21(DE3) cells) along with its unphosphorylated counterpart (8µg each) were hydrolyzed in ammonium
bicarbonate buffer at 37◦C for 16 h by in-solution trypsin digestion method. Samples were then used for LC-MS/MS analysis. Phospho-site identification was done
using protein pilot. Fragmentation spectrum is shown for the modified peptide bearing threonine-309 residue phosphorylated by PknA. Asterisk (*) indicates modified
Thr residue. (B) Thr-309 is predominantly phosphorylated by PknA in vivo. mPDE-T309A generated by site directed mutagenesis was tested for any alteration in
phosphorylation profile compared to the wild-type in western blotting probing with anti-phosphothreonine antibody (upper panel). The same blot following stripping
was probed with anti-His antibody served as loading control (lower panel). mFtsZ and PknA were used as internal controls for the experiment. (C) Quantitative analysis
to determine the arbitrary mean phosphorylation intensities of mPDE-P and mPDE-T309A-P from western blots were calculated using ImageJ (Abràmoff et al., 2004;
Schneider et al., 2012) and plotted utilizing Microcal Origin 5.0 software. Western blot shown is a representation of four independent experiments from three different
preparations. Notations used: mPDE-P, phosphorylated mPDE; mPDE-T309A-P, phosphorylated mPDE-T309A.
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lane 1 while kanamycin plus hygromycin for lanes 2, 3, and 4
of Figure 2C) and consistent with the previous reports (Yang
et al., 2001; Thakur and Chakraborti, 2006; Thakur et al., 2008;
Dar and Chakraborti, 2010). Moreover, since the translation
machinery of the cell was also engaged in simultaneous
expression of two different proteins (mPDE and PknA/PknA-
K42N; Figure 2C, lanes 2 and 4), their levels of expression
were hard to control. Ni-NTA purification of lysates, followed
by immunoblotting revealed that co-expression of mPDE with
PknA, but not with the kinase-dead variant PknA-K42N, was a
phospho-protein recognized by anti-phosphothreonine antibody
(Figure 2C, upper right panel lane 2). The presence of mPDE
was also confirmed in western blotting of samples probed with
anti-His antibody (Figure 2C, lower right panel).
We further expressed mPDE as His-tagged protein in
M. smegmatis, which has endogenous sensor kinases but no
orthologs of mPDE (Etienne et al., 2005; Narayan et al., 2007;
Podobnik et al., 2009). In fact, M. smegmatis is often used as
a model in carrying out genetic studies with M. tuberculosis
(Thakur and Chakraborti, 2008; Baronian et al., 2015; Zhou et al.,
2015). Western blotting using anti-phosphothreonine antibody
recognized His-tagged mPDE protein that phosphorylated in
cellular extracts (10µg/lane, Figure 3, lanes 2 and 3) and in
purified form (2.5µg, Figure 3, lane 4). Authenticity of mPDE
protein was confirmed utilizing polyclonal anti-mPDE antibody
(Figure 3, middle panel). The Ni-NTA purified mPDE protein
exhibited a dose-dependent increase in band intensity (inset,
Figure 3). Thus, our results strongly indicated mPDE as a
substrate of eukaryotic-type Ser/Thr protein kinases.
To elucidate, if transphosphorylation of mPDE is PknA
specific, we assessed the ability of other kinases belonging to
the same clade (PknB and PknL) for such activities utilizing
in vitro kinase assay. For this, we used full length PknA and
a basic protein like α-casein as internal controls. As shown
in Figure 4A, both PknB and PknL, like PknA were able
to transfer [γ-32P] to either α-casein or mPDE. However,
magnitude of transphosphorylation ability of different kinases,
as has been reflected in phosphorylated band intensity of
the substrates was found to be varied (Figure 4A, compare
lanes 2, 5, and 8 for α-casein or 3, 6, and 9 for mPDE).
Surprisingly, despite using same amount of kinase (PknA or
PknB or PknL) in transphosphorylation assay, the addition
of mPDE in reaction mixture always resulted in increased
band intensity for phospho-PknB compared to that of the
PknB alone (Figure 4A, compare upper and lower panels,
lanes 4 and 6). Of note, autorads/phosphoimaging scans with
kinases especially in fusion with MBP often exhibited bands at
around ∼45 kDa besides specific signals and this was consistent
with previous reports (Thakur and Chakraborti, 2006; Zhou
et al., 2015). These bands could either be phosphorylated protein
without fusion tag or degradation product(s) or non-specific
entities within the reaction mix. We further validated this
observation by immunoblotting of Ni-NTA purified mPDE from
E. coli BL21(DE3) cell lysates co-expressed with either PknB or
PknL using anti-phosphothreonine antibody. As observed with
PknA, mPDE protein was recognized by anti-phosphothreonine
antibody in all cases (Figure 4B, upper panel; see also Figure 2C,
right panel). Ponceau-S stained blot served as a loading control
for the same (see Figure S2) and authenticity of the protein
was confirmed by probing with anti-His antibody (Figure 4B,
lower panel). Interestingly, despite the loading of same amount
of mPDE, the phospho-mPDE as reflected in band intensity
varied with the kinase used (Figure 4B, compare upper and
lower panels). Thus, these findings argued in favor of in vitro
phosphorylating ability of mPDE by mycobacterial eukaryotic-
type Ser/Thr kinases belonging to Clade I.
It was further intriguing to identify the residues of mPDE
phosphorylated by PknA. For this purpose, lysate from
E. coli BL21(DE3) cells co-expressing His6-mPDE as well as
MBP-PknA was purified through Ni-NTA column, dialyzed,
trypsin-digested and finally used for LC-MS/MS analysis along
with unphosphorylated protein. Protein pilot and MASCOT
search led to the identification of Thr-309 of mPDE as the
phosphorylated residue with 99% confidence (Figure 5A; also
see Table S1). To confirm this observation, we generated
a mutant mPDE-T309A by site directed mutagenesis that
replaced threonine with alanine. Immunoblot analysis with anti-
phosphothreonine antibody showed that the mutant protein
(mPDE-T309A) was less phosphorylated than the wild-type
(Figure 5B; compare lanes 2 and 4). His6-mFtsZ, which is also
a substrate of PknA was used here as a control. Authenticity
of different proteins used in this experiment was confirmed
by western blotting with anti-His antibody. Quantitation
of phosphorylation intensity of bands from western blots
recognized by anti-phosphothreonine antibody through ImageJ
analysis (in arbitrary units; n = 4) revealed ∼8-fold decrease in
transphosphorylation of mPDE-T309A compared to that of the
wild-type mPDE (Figure 5C).
Phosphorylation of mPDE is Associated
with Its Cell Wall Localization
The crystal structure of mPDE revealed that the active site
comprising of metal and cAMP-binding sites are confined
within N-terminal 265 amino acid residues (Shenoy et al., 2007;
Podobnik et al., 2009). The C-terminal 20 amino acids, on the
other hand, is disordered as no electron density was observed for
this region (Podobnik et al., 2009; Matange et al., 2014). Available
reports indicated that the C-terminal region has patches, which
support protein localization to cell wall (Podobnik et al., 2009;
Matange et al., 2014). Thus, the presence of phosphorylating
Thr-309 residue (Figure 6A) fascinated us in evaluating the role
of phosphorylation on the protein. Kinetic analysis of enzyme
activities of mPDE andmPDE-T309A proteins exhibited a typical
Michaelis-Menten curve (Figure 6B) with comparable catalytic
(Km and Kcat) parameters (Inset, Figure 6B).
We further expressed both His6-mPDE and His6-mPDE-
T309A inM. smegmatis, prepared sub-cellular fractions (cytosol,
membrane, and cell wall) and compared protein profiles
in western blotting using anti-His or anti-mPDE antibody.
Although probing the protein with anti-His antibody yielded
non-specific bands, we observed band of expected molecular
mass of mPDE at membrane and cell wall fractions (Figure 7A
top and bottom panels, lanes 2 and 3). Such non-specific
band(s) is not unusual considering the fact that the cellular
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fractions might possess several proteins bearing stretch of
histidine residues, which would have been recognized by anti-
His antibody. The intensity of the band, however, at the expected
molecular size of mPDE in western blotting was more in cell wall
compared to that of the membrane fraction (Figure 7A, compare
lanes 2 and 3 of upper and lower panels). Comparative analysis on
the localization of mPDE-T309A vs. mPDE revealed that there
was no significant alteration in the distribution pattern of the
protein in membrane, but its intensity was significantly lower in
cell wall fraction (Figure 7A, see lanes 2 and 3 of top and bottom
panels). Considering the unaltered intensity of the non-specific
band at ∼70 kDa, variation seen in Figure 7A is independent
of expression artifact or loading defect in SDS-PAGE gel.
Subsequent mass spectrometry experimental results indicated
that the ∼70 kDa band seem to arise from a mixture of proteins
(GroEL/GntR family transcription regulator/phosphoglycerate
mutase/glyceraldehyde-3-phosphate dehydrogenase etc.) but not
mPDE (please see Table S2). In fact, these proteins were classically
considered to be restricted to cell interiors but have later
also shown to be cell surface/cell wall associated [please see
http://tuberculist.epfl.ch/ and references (Mawuenyega et al.,
FIGURE 6 | Comparison of catalytic activities of mPDE and
mPDE-T309A. (A) Schematic representation of domain architecture of mPDE.
Position of Thr-309 is indicated by asterisk. N and C denote amino- and
carboxy -terminal ends of mPDE respectively. (B) Kinetic analysis. His6-mPDE
and His6-mPDE-T309A proteins were purified through Ni-NTA columns.
Commercially available PDE assay kit was used to determine kinetic
parameters of mPDE and mPDE-T309A proteins as mentioned under
“Materials and Methods.” Insets show Coomassie stained gel with purified
wild-type (mPDE) and mutant (mPDE-T309A) proteins (3µg/lane) used for
determining catalytic parameters (table). Notation used: LMW, low molecular
weight marker.
2005; He and De Buck, 2010; Boradia et al., 2014)]. However,
intensity of this band varied from preparation to preparation
despite loading of the same amount of protein. The identity of
mPDE in M. smegmatis cell wall was also confirmed by mass
spectrometry (inset, Figure 7A; also see Table S3). To validate our
findings, we monitored the localization of mPDE/mPDE-T309A
in sub-cellular fractions using anti-mPDE antibody following
their overexpression in M. smegmatis. Our findings clearly
demonstrated that mutation of phosphorylating residue (Thr-
309) to alanine affected the localization of protein to cell wall
(Figure 7B, compare lanes 3 and 6 of upper panel), whereas
the presence of other non-specific bands obtained in Figure 7A
were not seen with mPDE specific antibody. Western blotting
using anti-RpoB antibody [predominantly a cytosolic marker,
see reference (Chao et al., 2013)] was performed to rule out
the possibility of cross-contamination between cellular fractions
prepared (Figure 7C, upper panel).
Available literature suggested that phosphorylation renders
negative charge to a protein, which in turn influences its
functionality (Wagner et al., 2004). To have an insight on this
aspect, we compared protein localization profiles of wild-type,
mPDE-T309A mutant, and phosphomimics (mPDE-T309D and
mPDE-T309E) in cell wall fractions following their expression
in M. smegmatis (Figure 8A, upper panel). Western blotting
using anti-mPDE antibody revealed that cell wall localization
of the protein was affected only in mPDE-T309A while both
the phosphomimics behaved like wild-type mPDE (Figure 8B).
Thus, our results established that eukaryotic-type Ser/Thr kinase
mediated phosphorylation of mPDE at C-terminal Thr-309
residue portrayed negative charge to the protein, which in turn
endorsed its cell wall localization.
Thr-309 is Conserved in M. tuberculosis
Complex
We further considered reciprocal best blast hits for mPDE
using MycoRRdb database (Midha et al., 2012) and protein
sequences for those whose functional annotation has been done
were procured fromNCBI (ncbi.nlm.nih.gov). Multiple sequence
alignment revealed a high sequence identity between the mPDE
orthologs in different mycobacterial species. Interestingly, Thr-
309 residue of mPDE is conserved in all the orthologs (Figure 9;
PDE sequences from M. smegmatis and M. avium were used as
outgroups), illustrating its probable evolutionary significance.
DISCUSSION
Signal transduction in mycobacteria involves highly efficient post
translational modification machinery and secondary messengers.
Cyclic AMP is one such secondary messenger, which is
produced in an exceptionally high amount compared to other
bacteria (Shenoy and Visweswariah, 2006). However, only single
phosphodiesterase (mPDE) is identified and characterized, which
regulates mycobacterial cAMP levels within cells (Shenoy et al.,
2005). Interestingly, its overexpression led to reduction in 3′, 5′-
cAMP level in E. coli or M. smegmatis by 30%, while it is of
50% in the case ofM. tuberculosis indicating a negative feedback
control is operational (Agarwal et al., 2009). Thus, existence of an
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FIGURE 7 | mPDE phosphorylation affects its cell wall localization. Phosphorylation influences sub-cellular localization of mPDE. pVV2-mPDE or
pVV2-mPDE-T309A were expressed in M. smegmatis. Following sub-cellular fractionation, samples (10µg protein/slot) were resolved in 10% SDS-PAGE and
subjected to immunoblotting. (A) Western Blotting with anti-His antibody. Upper and lower panels represent M. smegmatis sub-cellular fractions expressing wild-type
and mPDE-T309A proteins probed with anti-His antibody. Ponceau-S staining of this blot served as a loading control (see Figure S3). Inset represents the identity of
mPDE protein in M. smegmatis cell wall fraction through in-gel trypsin digestion followed by LC-MS/MS and analyzed by protein pilot software. (B) Western blotting
with anti-mPDE antibody to confirm sub-cellular localization of wild-type and mPDE-T309A proteins following expression in M. smegmatis. Reproducibility of western
blot results was verified atleast three times from two different protein preparations. Numbers indicate molecular weight markers in kDa. (C) Sub-cellular fractions did
not show any cross contamination. Upper panel indicates western blotting of cellular fractions of M. smegmatis expressing mPDE/mPDE-T309A utilizing anti-RpoB
antibody to probe localization of cytosolic marker RpoB in cells. Numbers indicate pre-stained molecular weight markers in kDa. Lower panels of (B,C) depict
Ponceau-S stained blots as loading controls for the experiments. Notations used: WCL, whole cell lysate; Msm, M. smegmatis; PM, pre-stained marker.
equilibrium between the levels of cellular cAMP synthesized and
degraded or exported out of the cells has already been postulated
(Bai et al., 2011). Apart from cAMP hydrolysis, mPDE also
plays a key role in maintaining cell wall permeability (Podobnik
et al., 2009; Matange et al., 2014) and regulating downstream
signaling independent of that mediated by cAMP receptor
protein (Matange et al., 2013). Similarly, a well-orchestrated
post translational machinery involving cascade of events through
phosphorylation and dephosphorylation is mediated by 11
eukaryotic-type Ser/Thr kinases and a cognate phosphatase in
M. tuberculosis which have been identified to regulate plethora
of cellular functions (Molle et al., 2006; Molle and Kremer,
2010; Pereira et al., 2011). Accordingly, in the current study
we assessed the ability of mycobacterial kinases belonging to
clade I (PknA/PknB/PknL) to transphosphorylate mPDE. Since,
mPDE is phosphorylated by all these kinases with varying degree,
our results shown in Figures 2, 4, offer first clue for it being
a probable substrate of mycobacterial eukaryotic-type Ser/Thr
kinases. Furthermore, mPDE is not a basic protein (calculated
pI = 6.1) so that it would be non-specifically phosphorylated
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by these kinases. At this juncture, it needs to be emphasized
here that recent genome-wide phosphoproteome mapping ofM.
tuberculosis did not identify mPDE as a phosphorylated protein
(Prisic et al., 2010; Prisic and Husson, 2014). However, this is not
unlikely considering the fact that experimental conditions might
influence the results of mass spectrometric data.
Like eukaryotes, where phosphorylation is one of the
important mechanisms to regulate phosphodiesterase activity
as well as its functionality (Omori and Kotera, 2007), such a
control has not yet been reported in prokaryotes. In this scenario,
our results argue that phosphorylation mediated regulation is
not confined to eukaryotes only. Interestingly, single threonine
residue (Thr-309) at extreme C-terminus of the protein was
predominantly phosphorylated with a significant number of
modified b and y ions generated in our mass spectrometric study
(Figure 5A). Moreover, when this residue was mutated to alanine
and co-expressed along with PknA in E. coli BL21(DE3) cells,
mPDE-T309A was rarely recognized by anti-phosphothreonine
antibody (Figure 5B). This highlights the importance of Thr-
309 as the phosphorylating residue. Conversely, mPDE-T309A
protein did not show any significant alteration in its enzymatic
activity compared to that of the wild-type mPDE (Figure 6B),
which did not seem to be inconsistent considering the mutation
at a non-catalytic site. Thus, in the absence of any Ser/Thr
phosphatase use of E. coli system as a surrogate host for the
expression of mycobacterial Ser/Thr kinases aided us in studying
occurrence of phosphorylation of mPDE.
We further introduced M. tuberculosis phosphodiesterase
gene under the control of an inducible promoter in non-
pathogenic saprophyte M. smegmatis, where intrinsic kinases
such as PknA, PknB and PknL are present but there is no close
orthologs of mPDE (Etienne et al., 2005; Narayan et al., 2007;
Podobnik et al., 2009). Monitoring the phosphorylation status of
the mPDE in such a scenario revealed it as a phospho-protein
(Figure 3), though the intensity of phospho-signal was quite low
compared to the protein purified from E. coli BL21(DE3) cells
(Figures 2, 4). This might be an effect of phosphatase present
in M. smegmatis along with multiple eukaryotic-type Ser/Thr
kinases. Surprisingly, we noticed an alteration between wild-type
and mPDE-T309A while monitoring sub-cellular localization
pattern of these proteins (Figures 7A,B, 8B). On the other
hand, Thr-309 when substituted with phosphomimics (Asp or
Glu) behaved similar to that of the wild-type (Figure 8B).
Such an observation illustrated the importance of the negative
charge of the protein (rendered by its phosphorylation) in cell
wall anchorage. Our findings are consistent with a previous
report demonstrating that phosphorylation at Thr-16 of PDE10A
in humans is necessary for its localization from membrane
to cytosol (Kotera et al., 2004; Charych et al., 2010). It
is therefore logical to infer that phosphorylation mediated
control of phosphodiesterases as evident in eukaryotes is also
a reality in mPDE despite distinction in their phylogenetic
placement (Figure 1). Furthermore, alignment of mPDE with
other mycobacterial PDE sequences also explicates Thr-309 as
a conserved entity in all the orthologs within M. tuberculosis
complex (Figure 9) suggesting its phosphorylation to be
an evolutionarily important phenomenon. Alternatively, the
FIGURE 8 | Cell wall localization of phosphomimics of mPDE. (A)
Monitoring protein expression levels in M. smegmatis whole cell extracts.
Whole cell lysates of M. smegmatis (10µg/slot, upper panel) expressing either
wild-type or phosphoablative or phosphomimetic mutants were resolved in
10% SDS-PAGE gel and subjected to immunoblotting utilizing anti-mPDE
antibody. (B) Phosphomimetic mutants localizes similar to wild-type. Cell wall
fraction (10µg/slot) isolated from M. smegmatis cells expressing mPDE or
mPDE-T309A/D/E was probed with anti-mPDE antibody (lower panel).
Ponceau-S stained blot represents loading control and numbers indicate
molecular mass of pre-stained molecular weight marker used in this study.
Notations used: WCL, whole cell lysate; Msm, M. smegmatis; PM, pre-stained
marker.
presence of proline or serine at+1 position of Thr-309 of mPDE
ortholgs (Figure 9) might be crucial to maintain the structural
dynamicity, thereby governing phosphorylation (at Thr-309) in
these proteins. Unraveling these aspects of mycobacterial signal
transductionmechanisms will therefore open up the new horizon
towards understanding ofM. tuberculosis basic biology.
CONCLUSION
Our results established that phosphorylation of mycobacterial
phosphodiesterase, which is mediated by eukaryotic-type Ser/Thr
kinases like PknA, leads to its cell wall localization. Thus,
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FIGURE 9 | Thr-309 is conserved in mPDE orthologs. Multiple sequence alignment of phosphodiesterase was performed between different mycobacterial
species. Reciprocal best blast hits of mPDE were obtained from MycoRRdb; manual comparative genomics was done to obtain phosphodiesterase from
M. smegmatis and M. avium; protein sequences were obtained from NCBI; alignment was done by Mega 6.0 software using Muscle algorithm. C-termini of these
sequences are displayed in the figure and conserved threonine is enclosed within red rectangular box.
this finding indeed insinuates the probable functional interplay
between two distinct signaling cascades, one catalyzing post
translational modification, and the other involving small
molecule trafficking. Further studies in this direction would
certainly be expedient to develop potential anti-mycobacterial
compounds in future.
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